Plant-based nanoparticles and phages reduce brain inflammation
Edible Plant-derived exosome-like nanoparticles (ELNs) and phage inhibit brain inflammation by targeting microglia and gut microbiota
This study is looking at how tiny particles made from plants like turmeric and ginger might help reduce brain inflammation, especially for people dealing with aging or Alzheimer's, by targeting specific brain cells that affect inflammation and overall brain health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisville NIH-funded |
| Lab location | 1 site (Louisville, United States) |
| Project ID | NIH-11038024 on NIH RePORTER |
What this research studies
This research investigates how edible plant-derived nanoparticles and phages can help reduce inflammation in the brain, particularly in conditions related to aging and Alzheimer's disease. The approach focuses on targeting microglial cells, which play a significant role in brain inflammation and blood-brain barrier function. By using nanoparticles from turmeric and ginger, the study aims to enhance brain health and restore normal function without harmful side effects. The methodology includes examining how these nanoparticles interact with gut microbiota and their effects on inflammatory markers.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults experiencing cognitive decline or symptoms related to Alzheimer's disease.
Not a fit: Patients with acute brain injuries unrelated to aging or chronic inflammatory conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new, natural treatments for brain inflammation and age-related cognitive decline.
How similar studies have performed: Previous research has shown promising results using plant-derived compounds for neuroprotection, suggesting potential success for this novel approach.
Where this research is happening
Louisville, United States
- University of Louisville — Louisville, United States (Active)
Researchers
- Principal investigator: Teng, Yun — University of Louisville
- Study coordinator: Teng, Yun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.